Not even posted, thanks for the insider info.
They did good with PATH, as well as I did, BLRX was started with TEVA investors and docs, PATH was bough out byTEVA, nice.........
Where is corrupt, co-byrne and jakoff33 hiding ............... tards
Sure, I will take your bet, brrx will not trade higher than $2.50 tomorrow and most likely with a CRL, it will close between $1.30 - $1.50
What say you?
I believe that even with approval we hang around the $2.25 - $2.50 range, a crl gets us back to the $1.20 - $1.30 range
We could have a PDUFA date for a gold standard anti psychotic drug BL1020, that also mildly helped with cognition. Can the unblinded study warrant the completion of the Eagle trial? Or does the unblinded study produce a licensing agreement with royalties from a large pharmaceutical firm with an anti psychotic that is soon to go off patent ?
Imagine BLRX going to $5.00 overnight from only the publication of the unblinded study for BL1020, could this be possible?
A doctor with acquisition experience and connections to big pharmaceutical firms. BLRX will be acquired before August 2014, guaranteed.
Keep watching, small float and low volume tends to attract the manipulators. Any over weighted selling or buying can influence a big change in the stocks share price. Watch the slow steady moves and that will tell you the direction the stock price is headed.
BL 1040 alone if approved in the CE registration trial will get the share price to the $9.00 range and approximately $250 mil in BLRS's pocket prior to marketing by Ikaria
BL 7050, is BL 1021 which is in phase 1 development however, a new and possibly better small molecule EDP 34, in vivo, fully funded, looks to have more potential. Waiting on news that it graduated to the preclinical stage.
BL 1021 may be licensed to another pharmaceutical firm for further development. BLRX is not to long away from a decimal point move to the right.
BLRX - $15.00 in 2014
BL 1040 & 5040 CE Registration trial to be completed by summer 2014, could grab 25 -30% of a combined $5 billion dollar a year market.
Good volume on green days, light volume on red days. Majority of the clinical trials current underway will not yield too much info until 3rd quarter 2014
I believe we may be getting some unexpected but good news soon?